The advantage of GLP-1 RAs over DPP-4 inhibitors was especially notable in CV death (1.4% vs 2.2%
Alcoholism: Ozempic Could Reduce Alcohol Use Disorder Obese patients who took semaglutide saw between a 50%-56% decrease in the risk of alcohol use disorder and the recurrence of it
Personalized Treatment Plan Based on your individual needs, we will create a personalized treatment plan
Not intended to diagnose, treat, cure, or prevent any disease
Novo Nordisk successfully completes the first phase 3a trial, PIONEER 1, with oral semaglutide
With seven additional Phase 3 readouts expected in 2026, retatrutide is emerging as a potential next-generation standard of care one that could fundamentally reshape the metabolic medicine landscape